ImmunAbs

ImmunAbs was established in 2017 by experts of global standard antibody therapeutics development. Our vision is "Hope for Patients, Dreams for Everyone. Currently, we have several antibody therapeutics in global standard development. Antibody is a protein produced by B cell that plays an important role in humoral immunity. Antibodies can specifical... ly bind to various foreign objects and mediate immune responses. Due to the specificity, high affinity, and ability to mediate various efficacy, antibodies have been developed as therapeutics since 1985. So far, more than 90 antibody therapeutics have been licensed for various indications. Of the top 10 world's best-selling drugs in 2019, seven were antibody therapeutics. Antibody therapeutic development requires various know-hows throughout the process, from screening candidates and manufacturing to characterization, BLA approval, and commercialization. ImmunAbs develops antibody therapeutics for orphan diseases, diabetic retinopathy, and diabetes based on its experience in developing antibody therapeutics that have been globally approved for sales in the U.S. and Europe.Read More